Key Metrics 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Classic Biotech & Exports Ltd (531670)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531670 NSE: Floriculture | Small Cap | Classic Biotech Share Price
BSE Share Price
Not Listed
Not Listed
Classic Biotech & Exports Ltd (531670)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 531670 NSE: Floriculture | Small Cap | Classic Biotech Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹3 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
11.7
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-22.22%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
8.30%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹5 Cr.
Face Value
₹10
All Time Low / High
₹1.50 / 61.85
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Mar'00 | Mar'01 | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 9.3% | 3.2% | -1% | -8.8% | -11.4% | -7.9% | -11.8% | -10.6% | -11.1% | -7.6% | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 1.8 | 1.6 | 1.6 | 1.1 | 0.8 | 1.1 | 1 | 1 | 0.9 | 0.7 | 1 |
| Sales YoY Gr. | - | -9.5% | -2.5% | -33.5% | -21% | 32.5% | -9.1% | -4% | -6.3% | -22.2% | - |
| Adj EPS ⓘ | 0.9 | -0 | -0.2 | -1.3 | -1.6 | -1 | -1.4 | -1.2 | -1.2 | -0.8 | -0.8 |
| YoY Gr. | - | -103.3% | NA | NA | NA | NA | NA | NA | NA | NA | - |
| BVPS (₹) ⓘ | 8.3 | 7.9 | 7.6 | 6 | 4.5 | 4.1 | 3.7 | 3.3 | 2.6 | 1.8 | 3.3 |
| Adj Net Profit ⓘ | 0.5 | -0 | -0.1 | -0.7 | -0.8 | -0.5 | -0.7 | -0.6 | -0.6 | -0.4 | -0 |
| Cash Flow from Ops. ⓘ | 0.8 | 0.1 | -0.4 | -0.2 | -0.4 | 0 | 0 | 0 | 0 | -0.1 | - |
| Debt/CF from Ops. ⓘ | 5 | 78.7 | -12.3 | -18.2 | -10.2 | 564.3 | 146.7 | 168.6 | 106.9 | -86.2 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -9.9% | -3.4% | -11.2% | -22.2% | ||||
| Adj EPS ⓘ | -198.5% | NA | NA | NA | ||||
| BVPSⓘ | -15.6% | -16.7% | -21.5% | -30.8% | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'00 | Mar'01 | Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 12 | -0.4 | -1.9 | -13.9 | -18.9 | -14.2 | -24.7 | -28 | -38.7 | -36.6 | -31.5 |
| Op. Profit Mgn % ⓘ | 44.3 | 23.1 | 9.2 | -33.9 | -55.9 | -15.7 | -39 | -31.7 | -34.9 | -13.4 | -18.5 |
| Net Profit Mgn % ⓘ | 25.8 | -1 | -5.8 | -64.3 | -94 | -45.7 | -71.9 | -64.9 | -69.6 | -57.2 | -57.6 |
| Debt to Equity ⓘ | 1.1 | 1.3 | 1.1 | 1.4 | 1.9 | 2.1 | 2.2 | 2.6 | 3.2 | 4.6 | - |
| Working Cap Days ⓘ | 67 | 71 | 93 | 144 | 130 | 105 | 149 | 194 | 218 | 268 | 0 |
| Cash Conv. Cycle ⓘ | -28 | -7 | 31 | 67 | 28 | 17 | 64 | 106 | 121 | 126 | 0 |
Valuation of Classic Biotech - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Classic Biotech & Exports Ltd FAQs
The current trading price of Classic Biotech on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Classic Biotech stood at ₹3.11 Cr
The latest P/E ratio of Classic Biotech as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Classic Biotech as of 31-Dec-1969 is 1.89.
The 52-week high of Classic Biotech is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Classic Biotech is ₹0.70 ( Cr.) .
Data is not available for this company.
No data found
No data found
About Classic Biotech & Exports Ltd
Classic Biotech & Exports, incorporated as a public limited company on June 8, 1994, has business activities in floriculture and tissue culture. The company grows cut flowers at Karimsonnen Hally near Bangalore with an installed capacity of 5.2 million roses and other cut flowers. It obtained technical assistance and marketing support from Oriental Floratech India, a pioneer in the Indian floriculture industry. The company exports cut flowers to the Middle East countries, Gulf countries and the Netherlands auctions.
Milestones:
1994 - Classic Biotech & Exports Ltd was incorporated as a public limited company on June 8. The company received the Certificate of Commencement of Business on June 23, 1994. The company is having its registered office at 133/B, Vengalarao Nagar, Hyderabad.
The company is in the process of setting up a floriculture project at Karimsonnen Hally near Bangalore.
1996 - The company entered into a marketing tie-up with Oriental Floratech India Limited (OFIL) for marketing cut flowers in Holland auctions and for direct markets in the Middle East and Gulf countries.
1997 - During the year under review the company completed three green houses including plantations.
1998 - Directors N Rama Sita, P V Rama Raju and N Jhansi Rani retire.
1999 - The company proposed to enter into Information & Technology with e-commerce based solutions and accordingly a resolution is placed before for the approval for amendment of objects clause.
P Padmavathi and A S S N Raju, directors retire.
2000 - The company, a flower grower from south India, developed an online auction portal christened 'Classicflora.com' to cater to the Indian cut flower trade targeting major flower markets in the Asia-Pacific Rim.
Classic Biotech and Exports (CBEL), engaged in floriculture activity, entered into a memorandum of understanding with Sanjisoft 2000 of Colorado Springs, US.
The company will establish two development centres, one each in Bangalore and Hyderabad. For domestic market capitalisation, it has tied up with the Bangalore-based Brainsoft.
The company is offering a full-fledged international flower auction portal - www.classicflora.com.
The company has a unique concept in diversifying into biotechnology particularly agricultural biotechnology and the company as already ventured and invested heavily in its IT division.
The board of directors decided to retain the company's original name Classic Biotech & Exports.
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
